Vertex Pharmaceuticals' GAAP net income for 2020 was $2.712 billion, up 2.3 times from $1.177 billion in the previous year. Revenues increased 49.1% to $6.206 billion from $4.163 billion a year earlier.
Vertex Pharmaceuticals' GAAP net income for 2020 was $2.712 billion, up 2.3 times from $1.177 billion in the previous year. Revenues increased 49.1% to $6.206 billion from $4.163 billion a year earlier. 
investors.vrtx.com
English (US) 